First Nationwide Use of Bracco's VUEWAY (gadopiclenol) Solution for Injection for MRI
Requiring half the gadolinium dosage compared to other macrocyclic gadolinium-based contrast agents (GBCAs) in approved indications in the U.S., gadopiclenol also has the highest relaxivity compared to approved GBCAs1-7